OCUL logo

OCUL
Ocular Therapeutix Inc

12,055
Mkt Cap
$1.78B
Volume
4.16M
52W High
$16.44
52W Low
$5.80
PE Ratio
-5.69
OCUL Fundamentals
Price
$8.18
Prev Close
$8.27
Open
$8.26
50D MA
$9.58
Beta
1.44
Avg. Volume
8.96M
EPS (Annual)
-$1.42
P/B
2.70
Rev/Employee
$159,849.23
$1,613.02
Loading...
Loading...
News
all
press releases
Cantor Fitzgerald L. P. Buys Shares of 201,865 Ocular Therapeutix, Inc. $OCUL
Cantor Fitzgerald L. P. purchased a new stake in Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) during the third quarter, according to its most recent filing with the SEC. The firm purchased 201,865 shares of the biopharmaceutical company's stock, valued at approximately $2,360,000. Cantor Fi...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
What to Make of VR Adviser's Big Ocular Therapeutix Sell-Down
Key PointsAdviser, LLC Sold 5,845,915 shares of Ocular Therapeutix; estimated transaction value $71.01 million based on quarterly average price...
Nasdaq News: Markets·4d ago
News Placeholder
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Short Interest Up 20.0% in February
Ocular Therapeutix, Inc. (NASDAQ:OCUL - Get Free Report) was the recipient of a large increase in short interest during the month of February. As of February 27th, there was short interest totaling...
MarketBeat·5d ago
News Placeholder
Ocular Therapeutix, Inc. $OCUL Shares Purchased by Avoro Capital Advisors LLC
Avoro Capital Advisors LLC grew its position in Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) by 38.5% in the 3rd quarter, according to its most recent disclosure with the Securities and...
MarketBeat·9d ago
News Placeholder
Rosalind Advisors Inc. Decreases Stock Position in Ocular Therapeutix, Inc. $OCUL
Rosalind Advisors Inc. decreased its stake in shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) by 67.2% during the 3rd quarter, according to the company in its most recent filing with...
MarketBeat·10d ago
News Placeholder
Relay Therapeutics (RLAY) Soars 5.4%: Is Further Upside Left in the Stock?
Relay Therapeutics (RLAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks·12d ago
News Placeholder
Ocular Therapeutix, Inc. $OCUL Shares Bought by Vanguard Group Inc.
Vanguard Group Inc. raised its position in Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) by 9.2% during the third quarter, according to the company in its most recent 13F filing with the...
MarketBeat·18d ago
News Placeholder
Short Interest in Ocular Therapeutix, Inc. (NASDAQ:OCUL) Grows By 27.8%
Ocular Therapeutix, Inc. (NASDAQ:OCUL - Get Free Report) saw a significant increase in short interest in February. As of February 13th, there was short interest totaling 14,706,215 shares, an...
MarketBeat·20d ago
News Placeholder
Ocular Therapeutix Breaks Above 200-Day Moving Average - Bullish for OCUL
In trading on Monday, shares of Ocular Therapeutix Inc (Symbol: OCUL) crossed above their 200 day moving average of $10.98, changing hands as high as $11.00 per share. Ocular Therapeutix Inc shares...
Nasdaq News: Markets·20d ago
News Placeholder
Ocular Therapeutix (NASDAQ:OCUL) Shares Up 17.4% - Should You Buy?
Ocular Therapeutix (NASDAQ:OCUL) Shares Up 17.4% - Should You Buy...
MarketBeat·20d ago
<
1
2
...
>

Latest OCUL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.